Diabetes Mellitus, Type 2 Clinical Trials in Fargo, North Dakota

3 studies are recruiting for diabetes mellitus, type 2 in Fargo, North Dakota right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

   This study is open to adults with type 2 diabetes, high blood pressure, and cardiovascular disease. People can join the study if they have these conditions and do not have a history of heart failure. The purpose of this study is to find out if a medicine called vicadrostat, when taken with empaglif…

   Stage

   Phase 3

   Ages

   18 and older

   Site

   Lillestol Research, LLC, Fargo, North Dakota

   Locations

   1143 in total

   Run by

   Boehringer Ingelheim

   See if you can join NCT07064473 on ClinicalTrials.gov

2. A Research Study Comparing How Well Different Doses of the Medicine UBT251 Lower Blood Sugar in People With Type 2 Diabetes

   The study is testing UBT251 in participants with type 2 diabetes. The purpose of this clinical study is to find out if UBT251 is effective and safe for treating participants with type 2 diabetes. Participants will either get UBT251, UBT251 placebo, semaglutide, or semaglutide placebo. Which treatme…

   Stage

   Phase 2

   Ages

   18 to 75

   Site

   Plains Clinical Research Center, LLC_Fargo, Fargo, North Dakota

   Locations

   70 in total

   Run by

   Novo Nordisk A/S

   See if you can join NCT07668388 on ClinicalTrials.gov

3. A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

   TRANSFORM is a prospective, randomized, open blinded endpoint (PROBE), event-driven, pragmatic trial in patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests the hypothesis that a Cleerly Coronary Artery Disease …

   Stage

   Not phased

   Ages

   55 and older

   Site

   Sanford Health, Fargo, North Dakota

   Locations

   125 in total

   Run by

   Cleerly, Inc.

   See if you can join NCT06112418 on ClinicalTrials.gov